Short Interest in Dominari Holdings Inc. (NASDAQ:DOMH) Drops By 8.2%

Dominari Holdings Inc. (NASDAQ:DOMH) was the recipient of a large drop in short interest in the month of July. As of July 31st, there was short interest totalling 4,500 shares, a drop of 8.2% from the July 15th total of 4,900 shares. Currently, 0.1% of the shares of the stock are sold short. Based on an average trading volume of 8,200 shares, the days-to-cover ratio is presently 0.5 days.

Dominari Stock Performance

NASDAQ:DOMH opened at $1.61 on Monday. The company has a fifty day moving average of $1.85 and a two-hundred day moving average of $2.15. Dominari has a fifty-two week low of $1.53 and a fifty-two week high of $3.20. The stock has a market capitalization of $9.56 million, a PE ratio of -0.34 and a beta of 0.95.

Dominari Company Profile

Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.